|
|
Previous Article | Table of Contents | Next Article 
Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors
on human acute myelocytic leukemia cells and relationship to the
proliferative response
LM Budel, IP Touw, R Delwel, SC Clark and B Lowenberg
Dr Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
Interleukin-3 (IL-3) and granulocyte-monocyte-colony-stimulating factor
(GM-CSF) stimulate proliferation of human acute myeloid leukemia (AML) in
vitro, although patterns of response among clinical cases are diverse.
Whether regulatory abnormalities related to growth factor responses in
human AML may establish the outgrowth of the neoplasm is unclear. We
determined receptor numbers and affinity for IL-3 and GM- CSF on human AML
cells using human recombinant IL-3 (rIL-3) and GM-CSF (rGM-CSF). In 13 of
15 cases of primary AML high-affinity (kd 26 to 414 pmol/L) receptors for
IL-3 were demonstrable on the cells. The average numbers of IL-3 receptors
ranged from 21 to 145 receptors per cell. Normal WBCs showed IL-3 receptors
on their surface at similar densities. IL-3 receptor positivity often
correlated with GM-CSF receptor positivity of AML; GM-CSF receptors were
demonstrated on the cells of 11 of 15 cases, although average numbers of
GM-CSF receptors were ten times greater. The in vitro response of the cells
to exogenous IL-3 or GM-CSF was examined by measuring thymidine uptake.
Because IL-3 and GM-CSF were potent inducers of DNA synthesis in vitro,
apparently relatively few receptors are required to permit activation of
growth. These experiments did not provide evidence for overexpression or
increased receptor sensitivity as an explanation for AML growth. In a
minority of cases, however, the cells were unable to respond to IL-3 (four
of 15 cases) or GM-CSF (four of 15 cases) despite normal receptor
availability on the cell surface.
Volume 74,
Issue 2,
pp. 565-571,
08/01/1989
Copyright © 1989 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
I. Jakupovic, V. L. Grandage, D. C. Linch, and A. Khwaja
Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells
Blood,
April 15, 2004;
103(8):
3230 - 3232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Testa, R. Riccioni, S. Militi, E. Coccia, E. Stellacci, P. Samoggia, R. Latagliata, G. Mariani, A. Rossini, A. Battistini, et al.
Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis
Blood,
September 26, 2002;
100(8):
2980 - 2988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Vallera, S.-Y. Seo, A. Panoskaltsis-Mortari, J. D. Griffin, and B. R. Blazar
Targeting myeloid leukemia with a DT390-mIL-3 fusion immunotoxin: ex vivo and in vivo studies in mice
Protein Eng. Des. Sel.,
September 1, 1999;
12(9):
779 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Terpstra, H. Rozemuller, D. A. Breems, E. J.C. Rombouts, A. Prins, D. J.P. FitzGerald, R. J. Kreitman, J. J. Wielenga, R. E. Ploemacher, B. Lowenberg, et al.
Diphtheria Toxin Fused to Granulocyte-Macrophage Colony-Stimulating Factor Eliminates Acute Myeloid Leukemia Cells With the Potential to Initiate Leukemia in Immunodeficient Mice, But Spares Normal Hemopoietic Stem Cells
Blood,
November 1, 1997;
90(9):
3735 - 3742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Gattei, M. Degan, A. Gloghini, A. De Iuliis, S. Improta, F. M. Rossi, D. Aldinucci, V. Perin, D. Serraino, R. Babare, et al.
CD30 Ligand Is Frequently Expressed in Human Hematopoietic Malignancies of Myeloid and Lymphoid Origin
Blood,
March 15, 1997;
89(6):
2048 - 2059.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lowenberg, W. van Putten, I. P. Touw, R. Delwel, and V. Santini
Autonomous Proliferation of Leukemic Cells in Vitro as a Determinant of Prognosis in Adult Acute Myeloid Leukemia
N. Engl. J. Med.,
March 4, 1993;
328(9):
614 - 619.
[Abstract]
[Full Text]
|
 |
|
|
|